Dilation Capital Management’s NVIDIA NVDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91M Sell
29,519
-58,462
-66% -$12M 2.38% 18
2026
Q1
$15.3M Sell
87,981
-33,880
-28% -$6.22M 7.7% 2
2025
Q4
$22.7M Buy
121,861
+24,065
+25% +$4.48M 10.45% 2
2025
Q3
$18.2M Sell
97,796
-13,615
-12% -$2.37M 9.04% 2
2025
Q2
$17.6M Buy
111,411
+56,931
+104% +$7.16M 9.38% 2
2025
Q1
$5.9M Sell
54,480
-15,275
-22% -$1.94M 7.17% 6
2024
Q4
$9.37M Buy
+69,755
New +$9.61M 8.64% 3

Other funds holding NVDA

Dilation Capital Management's NVDA Position: Q2 2026 in Review

Dilation Capital Management reduced its NVIDIA (NVDA) stake by 66% in Q2 2026, selling an estimated $12M and leaving 29,519 shares worth $5.91M. The position accounts for 2.38% of the portfolio, ranked #18.

Dilation Capital Management first reported a position in NVDA in Q4 2024 and has held it in 7 quarters since. The position peaked at $22.7M in Q4 2025. 5,962 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

  • Dilation Capital Management held 29,519 shares of NVIDIA worth $5.91M as of Q2 2026.
  • Dilation Capital Management sold 58,462 NVIDIA shares in Q2 2026, an estimated $12M.
  • NVIDIA made up 2.38% of Dilation Capital Management's portfolio in Q2 2026, its #18 holding.
  • Dilation Capital Management first reported a position in NVIDIA in Q4 2024 and has held it in 7 quarters since.
  • Dilation Capital Management's NVIDIA position peaked at $22.7M in Q4 2025.
  • 5,962 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on Dilation Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.